Director of the Department of Hematology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; MD from Ulm University, Germany; PhD in Science from Southeast University; Chief Physician, Professor, Doctoral Supervisor. Specializes in complex and refractory hematologic diseases, particularly plasma cell disorders (including multiple myeloma, Waldenström macroglobulinemia, amyloidosis, light chain deposition disease, POEMS syndrome, etc.), lymphoma, leukemia, and has extensive experience in hematopoietic stem cell transplantation. In the field of innovative therapies, especially CAR-T cell immunotherapy, has achieved numerous breakthrough results. Research Achievements Has published over a hundred SCI papers in professional journals such as JAMA Oncology, Blood, Lancet Haematology, and dozens of papers in core journals. Has led dozens of funded projects, including National Natural Science Foundation of China and international funds. Research Direction Mainly focuses on the field of plasma cell disorders, with emphasis on in-depth investigation of the mechanisms of relapse and drug resistance in multiple myeloma, and systematic exploration of optimization strategies related to targeted therapy and immunotherapy. Personal Honors Selected for the Shanghai "Pujiang Talent" Program, the 8th Shanghai Youth Science and Technology Elite, the "National People's Good Doctor (Hematologic Oncology) Special Contribution Award," "Shanghai Good Doctor," Huangpu District "Leading Talent," and the Shanghai Oriental Talent Program Top-notch Project, etc.